Loading...
XSTO
KDEV
Market cap9mUSD
Dec 05, Last price  
0.34SEK
1D
-2.62%
1Q
-65.43%
Jan 2017
-94.42%
IPO
-99.15%
Name

Karolinska Development AB

Chart & Performance

D1W1MN
XSTO:KDEV chart
P/E
—
P/S
48.71
EPS
—
Div Yield, %
—
Shrs. gr., 5y
26.46%
Rev. gr., 5y
-11.49%
Revenues
2m
-8.74%
2,322,00030,320,00013,895,00010,479,0009,943,0009,940,0005,030,0002,942,0005,360,0002,464,0003,073,0003,384,0002,651,0002,170,0002,300,0002,014,0001,838,000
Net income
-8m
L
-5,767,000-2,641,000-334,584,000-385,673,000-212,852,000197,163,000-375,815,000-1,054,673,000-216,832,000179,595,00030,510,000657,709,000-385,476,000353,847,000-145,038,0005,386,000-8,101,000
CFO
-28m
L+11.23%
-18,005,000-34,165,000-97,324,000-133,437,000-152,645,000-82,027,000-108,387,000-325,023,000-8,994,00011,331,00013,154,000-7,409,000-33,200,00016,701,000-32,534,000-25,021,000-27,830,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.
URL
https://www.karolinskadevelopment.com/
IPO date
Apr 15, 2011
Employees
8
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT